205 related articles for article (PubMed ID: 37071625)
1. Quality of anticoagulant control and patient experience associated with long-term warfarin in Canadian patients with non-valvular atrial fibrillation: A multicentre, prospective study.
Selby R; Kaus L; Sealey F; Koo M; Parpia S; Chan B; Seung SJ; Bradley C; Strauss R; Mittmann N
PLoS One; 2023; 18(4):e0284425. PubMed ID: 37071625
[TBL] [Abstract][Full Text] [Related]
2. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
Hirano T; Kaneko H; Mishina S; Wang F; Morita S
J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
[TBL] [Abstract][Full Text] [Related]
3. Time in therapeutic range and stability over time for warfarin users in clinical practice: a retrospective cohort study using linked routinely collected health data in Alberta, Canada.
McAlister FA; Wiebe N; Hemmelgarn BR
BMJ Open; 2018 Jan; 8(1):e016980. PubMed ID: 29382672
[TBL] [Abstract][Full Text] [Related]
4. Warfarin Management and Outcomes in Patients with Nonvalvular Atrial Fibrillation Within an Integrated Health Care System.
An J; Niu F; Zheng C; Rashid N; Mendes RA; Dills D; Vo L; Singh P; Bruno A; Lang DT; Le PT; Jazdzewski KP; Aranda G
J Manag Care Spec Pharm; 2017 Jun; 23(6):700-712. PubMed ID: 28530526
[TBL] [Abstract][Full Text] [Related]
5. Time in therapeutic range, quality of life and treatment satisfaction of patients on long-term warfarin for non-valvular atrial fibrillation: a cross-sectional study.
Ng DL; Malik NMBA; Chai CS; Goh GM; Tan SB; Bee PC; Gan GG; Said AB
Health Qual Life Outcomes; 2020 Oct; 18(1):347. PubMed ID: 33081816
[TBL] [Abstract][Full Text] [Related]
6. Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial.
Singer DE; Hellkamp AS; Piccini JP; Mahaffey KW; Lokhnygina Y; Pan G; Halperin JL; Becker RC; Breithardt G; Hankey GJ; Hacke W; Nessel CC; Patel MR; Califf RM; Fox KA;
J Am Heart Assoc; 2013 Feb; 2(1):e000067. PubMed ID: 23525418
[TBL] [Abstract][Full Text] [Related]
7. The Quality of Anticoagulation Therapy among Warfarin-Treated Patients with Atrial Fibrillation in a Primary Health Care Setting.
Urbonas G; Valius L; Šakalytė G; Petniūnas K; Petniūnienė I
Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30650565
[No Abstract] [Full Text] [Related]
8. Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM).
Ansell J; Hollowell J; Pengo V; Martinez-Brotons F; Caro J; Drouet L
J Thromb Thrombolysis; 2007 Apr; 23(2):83-91. PubMed ID: 17221328
[TBL] [Abstract][Full Text] [Related]
9. INR goal attainment and oral anticoagulation knowledge of patients enrolled in an anticoagulation clinic in a Veterans Affairs medical center.
Baker JW; Pierce KL; Ryals CA
J Manag Care Pharm; 2011 Mar; 17(2):133-42. PubMed ID: 21348546
[TBL] [Abstract][Full Text] [Related]
10. Chinese stroke patients with atrial fibrillation used Robert's age-adjusted warfarin loading protocol obtained good INR results within therapeutic range.
Luo W; Luo X; Chen S; Li J; Huang X; Rao Y; Xu W
Sci Rep; 2023 Oct; 13(1):18230. PubMed ID: 37880296
[TBL] [Abstract][Full Text] [Related]
11. Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study.
Rahme E; Godin R; Nedjar H; Dasgupta K; Tagalakis V
Thromb Res; 2021 Jul; 203():121-130. PubMed ID: 34000493
[TBL] [Abstract][Full Text] [Related]
12. Quality of warfarin management in primary care: Determining the stability of international normalized ratios using a nationally representative prospective cohort.
Liu S; Singer A; McAlister FA; Peeler W; Heran BS; Drummond N; Manca DP; Allan GM; Korownyk C; Kolber MR; Greiver M; Garrison SR
Can Fam Physician; 2019 Jun; 65(6):416-425. PubMed ID: 31189630
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the impact of warfarin time in therapeutic range on outcomes of patients with atrial fibrillation in Turkey: perspectives from the observational, prospective WATER Registry.
Turk UO; Tuncer E; Alioglu E; Yuksel K; Pekel N; Ozpelit E; Vuran O; Tengiz I
Cardiol J; 2015; 22(5):567-75. PubMed ID: 26100825
[TBL] [Abstract][Full Text] [Related]
14. Warfarin time in therapeutic range and its impact on healthcare resource utilization and costs among patients with nonvalvular atrial fibrillation.
Deitelzweig S; Evans M; Hillson E; Trocio J; Bruno A; Tan W; Lingohr-Smith M; Singh P; Lin J
Curr Med Res Opin; 2016; 32(1):87-94. PubMed ID: 26451675
[TBL] [Abstract][Full Text] [Related]
15. Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry.
Liang HF; Du X; Zhou YC; Yang XY; Xia SJ; Dong JZ; Lip GYH; Ma CS
Med Sci Monit; 2019 Jun; 25():4691-4698. PubMed ID: 31232394
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study in primary care of the stability of INR in patients treated with warfarin or fluindione for atrial fibrillation. The FLOWER study (FLuindione Or WarfarinE - Result INR)].
Giron A; Lambert C; Berland M; Schmidt J; Poinas L; Charuel E; Ménini T; Pereira B; Vorilhon P
Ann Cardiol Angeiol (Paris); 2022 Jun; 71(3):123-129. PubMed ID: 35039141
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulation Therapy in Patients with Non-valvular Atrial Fibrillation in a Private Setting in Brazil: A Real-World Study.
Silva PGMBE; Sznejder H; Vasconcellos R; Charles GM; Mendonca-Filho HTF; Mardekian J; Nascimento R; Dukacz S; Fusco MD
Arq Bras Cardiol; 2020 Mar; 114(3):457-466. PubMed ID: 32049154
[TBL] [Abstract][Full Text] [Related]
18. Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation.
Lind M; Fahlén M; Kosiborod M; Eliasson B; Odén A
Thromb Res; 2012 Jan; 129(1):32-5. PubMed ID: 21851969
[TBL] [Abstract][Full Text] [Related]
19. Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.
Szummer K; Gasparini A; Eliasson S; Ärnlöv J; Qureshi AR; Bárány P; Evans M; Friberg L; Carrero JJ
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28249846
[TBL] [Abstract][Full Text] [Related]
20. Patient factors against stable control of warfarin therapy for Japanese non-valvular atrial fibrillation patients.
Tomita H; Kadokami T; Momii H; Kawamura N; Yoshida M; Inou T; Fukuizumi Y; Usui M; Funakoshi K; Yamada S; Aomori T; Yamamoto K; Uno T; Ando S;
Thromb Res; 2013 Nov; 132(5):537-42. PubMed ID: 24071466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
